Gene · 1808
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review. | Front Aging Neurosci | 2022 | 36620775 | PubTator, text mining | PubMed |
| Targeting N-type calcium channels in young-onset of some neurological diseases. | Front Cell Dev Biol | 2022 | 36601540 | PubTator, text mining | PubMed |
| Toward structural-omics of the bovine retinal pigment epithelium. | Cell Rep | 2022 | 36577381 | PubTator, text mining | PubMed |
| Neuronal CRMP2 phosphorylation inhibition by the flavonoid, naringenin, contributes to the reversal of spinal sensitization and arthritic pain improvement. | Arthritis Res Ther | 2022 | 36564853 | PubTator, text mining | PubMed |
| HIV-1 gp120 Protein Activates Cyclin-Dependent Kinase 1, a Possible Link to Central Nervous System Cell Death. | Viruses | 2022 | 36560797 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| Axonal Regeneration: Underlying Molecular Mechanisms and Potential Therapeutic Targets. | Biomedicines | 2022 | 36551942 | PubTator, text mining | PubMed |
| Cell specific regulation of NaV1.7 activity and trafficking in rat nodose ganglia neurons. | Neurobiol Pain | 2022 | 36531612 | PubTator, text mining | PubMed |
| Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity. | Front Mol Neurosci | 2022 | 36504683 | PubTator, text mining | PubMed |
| Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism. | J Transl Med | 2022 | 36463238 | PubTator, text mining | PubMed |
| Dynamics and consequences of the HTLV-1 proviral plus-strand burst. | PLoS Pathog | 2022 | 36441826 | PubTator, text mining | PubMed |
| Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders. | Front Mol Neurosci | 2022 | 36438186 | PubTator, text mining | PubMed |
| Applications of nanobodies in brain diseases. | Front Immunol | 2022 | 36426363 | PubTator, text mining | PubMed |
| A Review of Proteins Associated With Neuroprotection and Regeneration in Alzheimer's Disease. | Cureus | 2022 | 36407141 | PubTator, text mining | PubMed |
| Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms. | Cardiovasc Diabetol | 2022 | 36380358 | PubTator, text mining | PubMed |
| Tocotrienol-Rich Fraction and Levodopa Regulate Proteins Involved in Parkinson's Disease-Associated Pathways in Differentiated Neuroblastoma Cells: Insights from Quantitative Proteomic Analysis. | Nutrients | 2022 | 36364894 | PubTator, text mining | PubMed |
| Immunosenescence in Neurological Diseases-Is There Enough Evidence? | Biomedicines | 2022 | 36359383 | PubTator, text mining | PubMed |
| NADPH Oxidase 5 (NOX5) Overexpression Promotes Endothelial Dysfunction via Cell Apoptosis, Migration, and Metabolic Alterations in Human Brain Microvascular Endothelial Cells (hCMEC/D3). | Antioxidants (Basel) | 2022 | 36358519 | PubTator, text mining | PubMed |
| In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC-Application towards Cancer Therapeutics. | Curr Issues Mol Biol | 2022 | 36354673 | PubTator, text mining | PubMed |
| Chromosome instability in neuroblastoma: A pathway to aggressive disease. | Front Oncol | 2022 | 36338721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1808/papers?page=11